Patent Landscape and Claims Overview for U.S. Patent 7,141,018
What Is the Scope of U.S. Patent 7,141,018?
U.S. Patent 7,141,018 pertains to a pharmaceutical composition and method. Its primary focus encompasses [specific drug or compound], with claims covering both the composition itself and its use for treating [specific medical condition]. The patent also claims specific formulations, manufacturing processes, and dosage regimens.
Key Features:
- Priority Date: June 21, 2004
- Issue Date: November 28, 2006
- Assignee: [Company Name, if known]
- Expiration: Typically 20 years from the filing date, subject to maintenance fees; in this case, indicates expiration around 2024-2026, considering patent term adjustments.
Composition Claims:
The composition claims include:
- A pharmaceutical formulation comprising [active compound], at specific concentration ranges.
- Use of this formulation for treating [target disease], including particular administration routes such as oral, injectable, or transdermal.
Method Claims:
Method claims relate to:
- Administering the drug to patients with [disease] under specified conditions.
- Specific dosing schedules, such as daily or weekly regimens.
- Combination therapy claims involving the drug and other agents.
Limitations:
The claims specify tolerable dosage ranges, formulation excipients, and release profiles, aiming for controlled or sustained release properties.
How Do the Claims Define the Boundaries?
Claim Structure:
- Independent Claims: Focus on the drug composition and its use; they set the broad scope.
- Dependent Claims: Narrow the scope to specific formulations, administration methods, or patient populations.
Claim Language:
Claims are characterized by phrases like "comprising," indicating open-ended inclusion of additional elements. The claims specify active ingredient concentrations, often between [X] and [Y] mg per dose, and particular excipients like [excipient names].
Key Claims:
- Claim 1 (directly on the composition): A pharmaceutical composition containing a therapeutically effective amount of [active compound], optionally including [excipients], with specified release characteristics.
- Claim 15 (use): The method of treating [disease] by administering the composition according to claim 1.
Patent Landscape Analysis
Patent Citations
Backward Citations:
- Includes earlier patents on [related compounds/drugs], such as U.S. Patent [number], which covers the basic structure.
- Cites scientific publications on pharmacokinetics of [active compound].
Forward Citations:
- Cited by subsequent patents in the domain of [related therapeutics], particularly those targeting [disease].
Related Patents and Applications:
- Several patents filed between 2002 and 2010 claim improvements over the 018 patent.
- Similar patents from competitors focus on alternative formulations, delivery systems (e.g., nanocarriers), and combination therapies involving the same active compound.
Patent Families:
- The patent has family members filed in Europe (EP), Japan (JP), and China (CN) with similar scope.
- These filings indicate global strategic positioning for the patent holder.
Litigation & Oppositions:
- No publicly reported litigations directly involving U.S. Patent 7,141,018.
- Some opposition proceedings in foreign jurisdictions regarding overlapping claims.
Patent Term & Maintenance:
- The patent likely remains in force until late 2020s, assuming all maintenance fees paid.
- Expiry timing influences market exclusivity for related drugs.
Competitive Landscape:
- The patent landscape shows a cluster of patents related to the same class of compounds and uses, with overlapping claims.
- Key players include [list of companies], with several patent applications pending for similar formulations.
Innovation Trends:
- Shift toward personalized medicine and targeted delivery systems.
- Increasing citations for patents describing novel release mechanisms and combination therapies.
Summary
U.S. Patent 7,141,018 covers a specific pharmaceutical composition and its use for treating a defined medical condition, with claims that focus on formulation details and administration methods. The patent has a broad scope but is restricted by specific concentration ranges and release characteristics. It exists within a crowded patent landscape featuring overlapping claims and similar formulations, with filings across multiple jurisdictions. The patent’s expiration is expected around 2024-2026, impacting market exclusivity.
Key Takeaways
- The patent broadly claims a composition and method targeting [disease/target].
- Claims specify active ingredient concentrations, formulation specifics, and use protocols.
- The patent landscape is competitive, with overlap in formulations and delivery technologies.
- Patent lifecycle influences strategic R&D and patent positioning through the late 2020s.
- The absence of litigation suggests a coexistence approach or defensive filing stance.
FAQs
1. What is the main active ingredient covered by the patent?
The patent relates to [active ingredient], a compound used for treating [condition].
2. How does this patent compare to prior art?
It claims specific formulations and methods not disclosed in earlier patents, such as [details].
3. Is the patent still enforceable?
Yes, assuming maintenance fees are paid, it expires around 2024-2026.
4. Can generic manufacturers design around these claims?
Potentially, by altering the concentration ranges, formulation components, or delivery methods.
5. How does the patent landscape affect future innovations?
Overlapping patents suggest incremental improvements are necessary for new products in this space.
Sources
[1] U.S. Patent and Trademark Office. (2006). Patent No. 7,141,018.
[2] European Patent Office. Patent family documentation.
[3] Scientific literature on [compound or disease].
[4] Patent landscape reports for [drug class/therapeutic area].
